MedPath

Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Behavioral: Audio Program
Registration Number
NCT03852017
Lead Sponsor
Northwestern University
Brief Summary

In this study, the researchers will examine the implementation feasibility, acceptability, and initial effects of a brief eHealth mindfulness intervention, compared to brief relaxing music, to reduce self-reported symptoms of fatigue, anxiety, depression and sleep disturbance in a sample of localized prostate cancer patients during the receipt of radiation therapy.

Detailed Description

Eligible patients will be recruited from Northwestern Medicine's Department of Radiation Oncology and Northwestern Memorial Hospital. Participants will complete an online questionnaire prior to beginning the intervention. Following implementation pre-testing, the intervention will begin on Week 2 of radiation therapy and last 4 weeks. Upon arrival for their treatment visit, they will receive the audio program from the clinic staff. They will start the program prior to their treatment. Participants will be asked to listen to the audio-program during their radiation treatment visits, using a Bluetooth-enabled MP3 player with speaker instead of headphones or earbuds because they are not permitted during radiation therapy. The patient's ears need to be free to hear a possible communication from the radiation therapists if need be. Audio program recordings will run 3-12 minutes. Participants will turn off the program after their audio session has ended and return the audio program to the clinic staff after their treatment visit. Participants will complete an online question immediately after completing the intervention, and again 1 and 3 months later.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
59
Inclusion Criteria
  • Diagnosed with clinically localized prostate cancer
  • Will receive at least 7 weeks of daily radiation therapy
  • At least 18 years of age
  • Able to speak and understand English
  • Cognitively intact and free of serious psychiatric illness (as determined by referring physician)
Read More
Exclusion Criteria
  • Regular user of mindfulness meditation, which is defined as ≥ 3 times a week for the past 4 weeks
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mindfulness Audio ProgramAudio ProgramMindfulness Audio Program is a daily audio-session, which teaches emotional self-regulation skills through the adoption of mindful awareness practices into one's life
Music Audio ProgramAudio ProgramMusic Audio Program is a daily audio session of peaceful and relaxing music
Primary Outcome Measures
NameTimeMethod
Program acceptability measured by a post-program survey at 4-weeksWeek 4

Program acceptability will be assessed using a brief, Likert-type survey assessing participant enjoyment, satisfaction, perceived benefit, and ease of use. Acceptability is defined as ≥70% of survey responses in affirmation of this.

Implementation feasibility measured by retention rateThroughout study completion, a total of four months.

This indicator of implementation feasibility for the program delivered is defined by the retention rate being \>/=70% (e.g., total number of individuals who remained in the trial until the end of requested participation/total number of individuals enrolled).

Implementation feasibility measured by enrollment rateBaseline

This indicator of implementation feasibility for the program being delivered is defined by the overall enrollment rate being \>/= 70% (e.g., total number of individuals enrolled/total number approached).

Implementation feasibility measured by intervention adherenceThroughout the study intervention period, a total of 4 weeks.

This indicator of implementation feasibility for the program delivered is defined by an adherence rate of \>/=70% of all possible listening opportunities during the study intervention period.

Secondary Outcome Measures
NameTimeMethod
Change in depression using the PROMIS Depression questionnairebaseline; Week 4; Month 1; Month 3

Participants were administered the PROMIS Depression questionnaire. Significant change was indicated by a p\<.05 on depression scores between baseline and follow up time points between study arms.

Significant change in anxiety using the PROMIS Anxiety questionnairebaseline; Week 4; Month 1; Month 3

Participants were administered the PROMIS Anxiety questionnaire. Significant change was indicated by a p\<.05 on anxiety scores between baseline and follow up time points between study arms.

Change in fear of recurrence using the MAX-PC Fear of Recurrence sub-scalebaseline; Week 4; Month 1; Month 3

Participants were administered the MAX-PC Fear of Recurrence questionnaire. Significant change was indicated by a p\<.05 on fear of recurrence scores between baseline and follow up time points between study arms.

Change in mindfulness using the Mindful Attention Awareness Scalebaseline; Week 4; Month 1; Month 3

Participants were administered the Mindful Attention Awareness Scale. Significant change was indicated by a p\<.05 on mindfulness scores between baseline and follow up time points between study arms.

Significant change in fatigue using the PROMIS Fatigue questionnairebaseline; Week 4; Month 1; Month 3

Participants were administered the PROMIS Fatigue questionnaire. Significant change was indicated by a p\<.05 on fatigue scores between baseline and follow up time points between study arms.

Change in sleep using the PROMIS Sleep Disturbance questionnairebaseline; Week 4; Month 1; Month 3

Participants were administered the PROMIS Sleep Disturbance questionnaire. Significant change was indicated by a p\<.05 on sleep disturbance scores between baseline and follow up time points between study arms.

Change in uncertainty intolerance using the Intolerance for Uncertainty Scalebaseline; Week 4; Month 1; Month 3

Participants were administered the Intolerance for Uncertainty questionnaire. Significant change was indicated by a p\<.05 on uncertainty intolerance scores between baseline and follow up time points between study arms.

© Copyright 2025. All Rights Reserved by MedPath